196 related articles for article (PubMed ID: 26620594)
21. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
23. Double-effective chitosan scaffold-PLGA nanoparticle system for brain tumour therapy: in vitro study.
Kutlu C; Çakmak AS; Gümüşderelioğlu M
J Microencapsul; 2014; 31(7):700-7. PubMed ID: 24963961
[TBL] [Abstract][Full Text] [Related]
24. Down regulation of miR-18a, miR-21 and miR-221 genes in gastric cancer cell line by chrysin-loaded PLGA-PEG nanoparticles.
Mohammadian F; Pilehvar-Soltanahmadi Y; Mofarrah M; Dastani-Habashi M; Zarghami N
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1972-1978. PubMed ID: 26772615
[TBL] [Abstract][Full Text] [Related]
25. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL
Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292
[TBL] [Abstract][Full Text] [Related]
26. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
Yang Y; Xie XY; Mei XG
Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
[TBL] [Abstract][Full Text] [Related]
27. Oleanolic-bioenhancer coloaded chitosan modified nanocarriers attenuate breast cancer cells by multimode mechanism and preserve female fertility.
Sharma M; Sharma S; Sharma V; Sharma K; Yadav SK; Dwivedi P; Agrawal S; Paliwal SK; Dwivedi AK; Maikhuri JP; Gupta G; Mishra PR; Rawat AKS
Int J Biol Macromol; 2017 Nov; 104(Pt A):1345-1358. PubMed ID: 28591594
[TBL] [Abstract][Full Text] [Related]
28. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
[TBL] [Abstract][Full Text] [Related]
29. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo evaluation of Δ⁹-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy.
Martín-Banderas L; Muñoz-Rubio I; Prados J; Álvarez-Fuentes J; Calderón-Montaño JM; López-Lázaro M; Arias JL; Leiva MC; Holgado MA; Fernández-Arévalo M
Int J Pharm; 2015 Jun; 487(1-2):205-12. PubMed ID: 25899283
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
[TBL] [Abstract][Full Text] [Related]
32. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
Wang YD; Hu Y; Zhang L; Huang J; Sun CY
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169
[TBL] [Abstract][Full Text] [Related]
33. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
[TBL] [Abstract][Full Text] [Related]
34. Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.
Di Martino MT; Leone E; Amodio N; Foresta U; Lionetti M; Pitari MR; Cantafio ME; Gullà A; Conforti F; Morelli E; Tomaino V; Rossi M; Negrini M; Ferrarini M; Caraglia M; Shammas MA; Munshi NC; Anderson KC; Neri A; Tagliaferri P; Tassone P
Clin Cancer Res; 2012 Nov; 18(22):6260-70. PubMed ID: 23035210
[TBL] [Abstract][Full Text] [Related]
35. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
36. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
Callewaert M; Dukic S; Van Gulick L; Vittier M; Gafa V; Andry MC; Molinari M; Roullin VG
J Biomed Mater Res A; 2013 May; 101(5):1319-27. PubMed ID: 23065812
[TBL] [Abstract][Full Text] [Related]
37. Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment.
Sharma S; Pukale S; Sahel DK; Singh P; Mittal A; Chitkara D
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112305. PubMed ID: 34474856
[TBL] [Abstract][Full Text] [Related]
38. The inhibitory effect of disulfiram encapsulated PLGA NPs on tumor growth: Different administration routes.
Fasehee H; Zarrinrad G; Tavangar SM; Ghaffari SH; Faghihi S
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():587-95. PubMed ID: 27040254
[TBL] [Abstract][Full Text] [Related]
39. Incorporation of PLGA nanoparticles into porous chitosan-gelatin scaffolds: influence on the physical properties and cell behavior.
Nandagiri VK; Gentile P; Chiono V; Tonda-Turo C; Matsiko A; Ramtoola Z; Montevecchi FM; Ciardelli G
J Mech Behav Biomed Mater; 2011 Oct; 4(7):1318-27. PubMed ID: 21783141
[TBL] [Abstract][Full Text] [Related]
40. Platelet compatibility of PLGA, chitosan and PLGA-chitosan nanoparticles.
Li X; Radomski A; Corrigan OI; Tajber L; De Sousa Menezes F; Endter S; Medina C; Radomski MW
Nanomedicine (Lond); 2009 Oct; 4(7):735-46. PubMed ID: 19839810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
